Hybrid Conferencee

International Conference on Cancer Biology and Molecular Oncology (ICCBMO - 26)

6th - 7th October 2026 | Washington DC, USA

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Washington DC. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Washington DC event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Washington DC conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Washington DC, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Washington DC."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Molecular Mechanisms of Tumorigenesis

This session will explore the intricate molecular pathways involved in tumorigenesis, focusing on the roles of oncogenes and tumor suppressor genes. Discussions will include recent advancements in understanding the genetic and epigenetic alterations that drive cancer development.

Track 02

Cancer Signaling Pathways

This track will delve into the complex signaling networks that regulate cell proliferation and apoptosis in cancer. Participants will examine how dysregulation of these pathways contributes to tumor growth and metastasis.

Track 03

Targeted Therapies in Oncology

This session will highlight the latest innovations in targeted therapies aimed at specific molecular targets in cancer cells. Emphasis will be placed on the mechanisms of action, efficacy, and resistance associated with these therapeutic approaches.

Track 04

Cancer Genomics and Epigenetics

This track will focus on the integration of genomic and epigenetic data to understand cancer biology. Researchers will present findings on how these layers of regulation influence tumor behavior and patient outcomes.

Track 05

Tumor Microenvironment and Angiogenesis

This session will investigate the interactions between tumor cells and their microenvironment, with a particular focus on angiogenesis. Discussions will include how these interactions facilitate cancer progression and therapeutic resistance.

Track 06

Cancer Stem Cells and Metastasis

This track will explore the role of cancer stem cells in tumor initiation and metastasis. Researchers will discuss the unique properties of these cells and their implications for treatment strategies.

Track 07

Molecular Diagnostics in Cancer

This session will cover the advancements in molecular diagnostics that enhance cancer detection and monitoring. Topics will include the development of biomarkers and their clinical applications in personalized medicine.

Track 08

Chemotherapy Resistance Mechanisms

This track will examine the biological mechanisms underlying chemotherapy resistance in cancer treatment. Researchers will present novel strategies to overcome resistance and improve therapeutic efficacy.

Track 09

Cancer Immunology and Therapeutics

This session will focus on the immune system's role in cancer biology and the development of immunotherapeutic strategies. Topics will include immune checkpoint inhibitors, CAR T-cell therapy, and the tumor immune microenvironment.

Track 10

Biomarker Discovery and Clinical Applications

This track will highlight the latest research in biomarker discovery for cancer diagnosis and prognosis. Emphasis will be placed on translating these findings into clinical practice to improve patient outcomes.

Track 11

Cancer Progression and Therapeutic Strategies

This session will explore the dynamic processes of cancer progression and the development of innovative therapeutic strategies. Discussions will include the integration of multi-omics approaches to understand and combat cancer.